[新冠长期症状背景下新冠疫苗接种的价值]
[The value of COVID-19 vaccination in the context of Long-COVID].
作者信息
Bauernfeind Stilla, Schmidt Barbara
机构信息
Abteilung für Krankenhaushygiene und Infektiologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.
Institut für Klinische Mikrobiologie und Hygiene, Universitätsklinikum Regensburg, Regensburg, Deutschland.
出版信息
Inn Med (Heidelb). 2022 Aug;63(8):840-850. doi: 10.1007/s00108-022-01368-y. Epub 2022 Jul 7.
Abstract
There are currently no strategies available on how to deal with Long-COVID (COVID "coronavirus disease"). COVID-19 vaccination could be both a preemptive and a therapeutic option for the future. The evaluation of the available studies is complicated by varying definitions. There are, however, indications that (complete) COVID-19 vaccination is able not only to prevent symptomatic infection but also to reduce the risk of Long-COVID. In some patients with Long-COVID, symptoms are modified after (first and/or second) COVID-19 vaccination; however, there is no clear evidence for a real therapeutic effect on Long-COVID.
摘要
目前尚无应对长期新冠（新冠“冠状病毒病”）的策略。新冠疫苗接种未来可能既是一种预防措施，也是一种治疗选择。现有研究的评估因定义不同而变得复杂。然而，有迹象表明，（完整的）新冠疫苗接种不仅能够预防有症状感染，还能降低长期新冠的风险。在一些长期新冠患者中，（首次和/或第二次）新冠疫苗接种后症状有所改善；然而，尚无明确证据表明对长期新冠有真正的治疗效果。
相似文献
1
[The value of COVID-19 vaccination in the context of Long-COVID].
Inn Med (Heidelb). 2022 Aug;63(8):840-850. doi: 10.1007/s00108-022-01368-y. Epub 2022 Jul 7.
2
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.
Int J Environ Res Public Health. 2022 Sep 29;19(19):12422. doi: 10.3390/ijerph191912422.
3
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
4
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
Vaccine. 2023 Mar 10;41(11):1783-1790. doi: 10.1016/j.vaccine.2023.02.008. Epub 2023 Feb 8.
5
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
Clin Microbiol Infect. 2022 Aug;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016. Epub 2022 Mar 23.
6
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol. 2021 Sep 29;12:742914. doi: 10.3389/fimmu.2021.742914. eCollection 2021.
8
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4.
9
Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.
Am J Epidemiol. 2024 Aug 5;193(8):1106-1114. doi: 10.1093/aje/kwad225.
10
15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
Front Immunol. 2023 Sep 12;14:1226622. doi: 10.3389/fimmu.2023.1226622. eCollection 2023.
引用本文的文献
1
How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.
BMC Public Health. 2024 Mar 28;24(1):915. doi: 10.1186/s12889-024-18380-6.
2
Exploring the Impact of COVID-19 on Physical Activity One Month after Infection and Its Potential Determinants: Re-Infections, Pre-Illness Vaccination Profiles/Types, and Beyond.
Vaccines (Basel). 2023 Aug 29;11(9):1431. doi: 10.3390/vaccines11091431.
3
A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
Epidemiol Infect. 2023 Aug 18;151:e145. doi: 10.1017/S0950268823001279.
4
[Long COVID-a new challenge].
Inn Med (Heidelb). 2022 Aug;63(8):811-812. doi: 10.1007/s00108-022-01376-y. Epub 2022 Jul 20.
本文引用的文献
1
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.
PLoS One. 2022 Dec 20;17(12):e0278825. doi: 10.1371/journal.pone.0278825. eCollection 2022.
2
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study.
Open Forum Infect Dis. 2022 Sep 12;9(9):ofac464. doi: 10.1093/ofid/ofac464. eCollection 2022 Sep.
3
'Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': authors' response.
Clin Microbiol Infect. 2022 Oct;28(10):1397-1398. doi: 10.1016/j.cmi.2022.06.003. Epub 2022 Jul 14.
4
The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID.
Vaccines (Basel). 2022 Apr 21;10(5):652. doi: 10.3390/vaccines10050652.
5
Long COVID after breakthrough SARS-CoV-2 infection.
Nat Med. 2022 Jul;28(7):1461-1467. doi: 10.1038/s41591-022-01840-0. Epub 2022 May 25.
6
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.
BMJ. 2022 May 18;377:e069676. doi: 10.1136/bmj-2021-069676.
7
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
Brain Behav Immun. 2022 Jul;103:154-162. doi: 10.1016/j.bbi.2022.04.013. Epub 2022 Apr 18.
8
Association of Vaccination with the Persistence of Post-COVID Symptoms.
J Gen Intern Med. 2022 May;37(7):1748-1753. doi: 10.1007/s11606-022-07465-w. Epub 2022 Mar 9.
9
Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2.
J Gen Intern Med. 2022 May;37(6):1585-1588. doi: 10.1007/s11606-022-07443-2. Epub 2022 Feb 22.
10
Vaccines may cause rare, Long Covid-like symptoms.
Science. 2022 Jan 28;375(6579):364-366. doi: 10.1126/science.ada0536. Epub 2022 Jan 27.
Zotero 插件